Search

Your search keyword '"Richart, C"' showing total 645 results

Search Constraints

Start Over You searched for: Author "Richart, C" Remove constraint Author: "Richart, C"
645 results on '"Richart, C"'

Search Results

2. Platelet-associated biomarkers in nonalcoholic steatohepatitis: Insights from a female cohort with obesity

4. LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus

5. Increased Hepatic ATG7 mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity

6. Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease

7. The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease

8. LC/MS-Based Untargeted Metabolomics Study in Women with Nonalcoholic Steatohepatitis Associated with Morbid Obesity

10. Lipocalin, Resistin and Gut Microbiota-Derived Propionate Could Be Used to Predict Metabolic Bariatric Surgery Selected Outcomes

11. Expression of Jejunal Taste Receptors in Women with Morbid Obesity

12. Deregulation of secreted frizzled-related protein 5 in nonalcoholic fatty liver disease associated with obesity

15. Deregulated serotonin pathway in women with morbid obesity and nafld

16. Circulating microbiota-derived metabolites: a “liquid biopsy?

20. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. (Inflammation and Inflammatory Bowel Disease)

26. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients

28. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

35. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease

37. A case of coconut allergy

44. Hepatic alcohol dehydrogenase activity in alcoholic subjects with and without liver disease

48. Targeted metabolomic approach in men with carotid plaque

49. Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy

Catalog

Books, media, physical & digital resources